## Abstract Hepatitis type B remains an important disease globally. Rapid advances have been made during the last two decades in the understanding of the biology of HBV, the complex interaction between the virus and the host, and the pathology and the clinical aspects of infection. Mass vaccination
Progress in the prevention and control of viral hepatitis type B
โ Scribed by A. Mele; M. Rizzetto; T. Stroffolini; A. Zanetti
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 14 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract About 170 million Chinese are infected chronically with HBV and 10% suffer from chronic hepatitis. Around half a million Chinese die from hepatitis B caused hepatocellular carcinoma and endstage cirrhosis each year. From 1983 to the present, a controlled clinical trial involving 80,000
apologize for giving the wrong Rojkind reference. For historical interest, we used the 1976 (3) publication, but by error, referred to the 1979 one ( 1). Dr. W. J. Lindblad makes an excellent point. The methods section was markedly abbreviated and the paper, as published, does give the misleading i
Despite federal, state, and local public health efforts to prevent and control hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, these diseases remain serious health problems in the United States. About 1%-2% of the U.S. population has chronic HBV or HCV infections, and each year about
In our double-blind randomized trial of methylprednisolone vs. placebo in severe viral hepatitis, 16 patients with hepatitis B (8 on steroid, 8 on placebo) were followed for at least 4 weeks. Four of the eight patients receiving methylprednisolone eventually died and all patients on placebo survived